Waltham, Mass (PRWEB) May 22, 2012
AsisChem, a boutique drug discovery partner for small biotech and pharma companies, is proud to announce the addition of Diane L Kozwich, Ph.D. to its senior leadership team. Dr. Kozwich will serve as the vice president of business development, working with existing and new partners to carry out novel drug research and discovery projects.
“Diane brings to us a wealth of scientific and operational experience,” said Dr. Ilya Kuchuk, AsisChem’s founder and CEO. “She has strengthened our ability to offer cutting edge drug discovery services seamlessly from concept stages to investigational new drug (IND) application.”
Dr. Kozwich has more than 20 years’ experience as an inventor, scientist and biotechnology business executive. She is a biochemist, with expertise in molecular biology and immunology. Dr. Kozwich was co-founder and COO at Xtrana Inc, a public molecular diagnostic company located in Denver, CO, where she headed the development of the company’s lead product. Diane Kozwich lead the business development and commercialization of the world first portable forensic DNA analysis instrument while VP of Technology at Network Biosystems (NetBio). As VP of Business Development at Sage Science, an instrument company, she helped to secure a partnership with a leading biotechnology company and led the development of a first of its kind electrophoresis instrument.
About AsisChem, Inc.
AsisChem is a leading niche CRO in custom synthesis and medicinal chemistry. Since 2005 the company’s scientists have helped over one hundred biotech, pharmaceutical, academic and government research teams advance their drug discovery projects. For more information, email info(at)asischem(dot)com or visit http://www.asischem.com/custom-synthesis-research-chemicals.aspx.